Hypopituitarism oddities: craniopharyngiomas

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

Craniopharyngiomas are tumours associated with significant long-term pituitary dysfunction. The rates of anterior pituitary hormone deficits are not influenced by treatment modality and do not differ between childhood- and adult-onset disease. The apparent paradox of growth in the absence of growth hormone (GH) has been reported in children with this tumour and is not, as yet, completely understood. GH replacement therapy offers significant benefits for both children and adults (although adult patients are less likely to lose weight or body fat). Based on results of retrospective studies, GH therapy does not seem to increase the risk of tumour recurrence.

Original languageEnglish
Pages (from-to)151-3
Number of pages3
JournalHormone Research
Volume68 Suppl 5
DOIs
Publication statusPublished - 2007

Bibliographical note

Copyright (c) 2007 S. Karger AG, Basel.

Keywords

  • Craniopharyngioma
  • Growth Hormone
  • Hormone Replacement Therapy
  • Hormones
  • Humans
  • Hypopituitarism
  • Neoplasm Recurrence, Local
  • Pituitary Neoplasms
  • Risk Assessment

Fingerprint

Dive into the research topics of 'Hypopituitarism oddities: craniopharyngiomas'. Together they form a unique fingerprint.

Cite this